GeraClinic / NHS cancer waiting times / NHS West Yorkshire ICB / Breast Symptomatic
NHS West Yorkshire ICB: Breast Symptomatic — 62-Day Cancer Waits
In April 2026, 93.8% of breast symptomatic cancer patients in NHS West Yorkshire ICB started treatment within 62 days — 16 patients on this pathway. NHS target: 85%. Official NHS England data.
What is the Breast Symptomatic cancer waiting time in NHS West Yorkshire ICB?
As of April 2026, 93.8% of breast symptomatic cancer patients in NHS West Yorkshire ICB started treatment within 62 days of referral (15 of 16 patients, NHS target: 85%), per NHS England Cancer Waiting Times data published June 2026. Gera re-dates this monthly.
| Measure | Value | Context |
|---|---|---|
| Patients on pathway | 16 | April 2026 |
| Within 62 days | 15 | Started treatment in time |
| Breaches | 1 | Did not meet 62-day standard |
| 62-day standard met | 93.8% | NHS target: 85% |
| Status vs target | MET | Target is 85% |
Other cancer pathways in NHS West Yorkshire ICB
NHS West Yorkshire ICB Breast Symptomatic cancer waits: FAQs
- What is the 62-day cancer waiting time for Breast Symptomatic in NHS West Yorkshire ICB?
- In April 2026, 93.8% of breast symptomatic cancer patients in NHS West Yorkshire ICB started treatment within 62 days of referral — covering 16 patients (15 within standard, 1 breaches). NHS target: 85%. Data: NHS England Cancer Waiting Times, June 2026.
- What does the Breast Symptomatic pathway mean?
- The Breast Symptomatic pathway covers patients referred with breast symptoms that do not meet the 2-week-wait criteria but are nonetheless seen within the cancer waiting times framework. These patients are often referred by GPs for non-urgent assessment of breast lumps or pain.
- How does NHS West Yorkshire ICB's Breast Symptomatic performance compare to England?
- The England average for the 62-day Breast Symptomatic pathway was not separately published at England level in the April 2026 extract. NHS West Yorkshire ICB's 93.8% performance can be compared against the overall England 62-day combined standard met rate and the NHS 85% target.
- What counts as a breach of the 62-day cancer standard?
- A breach occurs when a patient does not start their first definitive cancer treatment within 62 days of the relevant referral date (2-week wait, upgrade, screening referral, or breast symptomatic). In NHS West Yorkshire ICB for the Breast Symptomatic pathway in April 2026, there were 1 breaches out of 16 patients.
Faster breast symptomatic cancer assessment
NHS West Yorkshire ICB met the NHS 85% 62-day standard for the Breast Symptomatic pathway in April 2026. For even faster specialist access, GeraClinic connects you to UK-registered oncologists.
Contains public sector information published by NHS England and licensed under the Open Government Licence v3.0. Data: Cancer Waiting Times CRS Database, April 2026. Methodology.